Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH
1.81 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities: | ||||||
| Net Income
| -39.261 | -24.339 | -8.522 | -3.783 | -0.847 | -1.68 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0.001 | 0.001 | 0.018 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 3.413 | 0.177 | 0.107 | 0 | 0 | 0.021 |
| Change In Working Capital
| 7.284 | 5.007 | -0.702 | -2.33 | 0.634 | 0.542 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.329 | 3.011 | -0.498 | 0.775 | 0.158 | 0 |
| Other Working Capital
| 6.955 | 1.997 | -0.204 | -3.105 | 0.476 | 0.542 |
| Other Non Cash Items
| 0.239 | 0.195 | -1.551 | 2.387 | -0.006 | 0.028 |
| Operating Cash Flow
| -28.324 | -18.961 | -10.668 | -3.726 | -0.218 | -1.071 |
| Investing Activities: | ||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities: | ||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 27.494 | 7.774 | 31.497 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 5.678 | 0.019 | 0.098 | 12.827 | 0 | 0.175 |
| Financing Cash Flow
| 33.172 | 7.792 | 31.596 | 12.827 | 0.1 | 0.175 |
| Other Information: | ||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 4.848 | -11.168 | 20.927 | 8.76 | -0.118 | 0.119 |
| Cash At End Of Period
| 23.367 | 18.52 | 29.688 | 8.76 | 0 | 0.119 |